Back in March we reported on Diagnosia, a startup that is aiming to become “a search engine for drugs” by providing a safe place for people looking up medicine information.
Today it’s a secured an undisclosed “6-figure” seed round (though we know they were looking for €200,000) into the Vienna-based startup. The round was led by Johann Hansmann, a former pharma entrepreneur and now active angel investor whose recent investments include the leading language learning tool busuu, weight-loss startup iJoule and luxury online retailer Renesim. He was joined by Christoph Sauermann, a former pharma executive and tech entrepreneur.
Diagnosia basically aggregates those little leaflets you find in packets of prescription drugs and puts them online in a user friendly and accessible format across multiple formats and languages. The attraction to doctors is that none of this information is usually online, so this makes it way asier for them. Patients too, find this useful. And hypochondriacs, it must be said…
The money will primarily be used for internationalization and they also plan to move into making the site a “drug decision tool”.
Diagnosia’s competitors are largely U.S.-based, including Rxlist, Drugs.com and Epocrates.
The team consists of Marco Vitula, Co-Founder and CEO, along with Fritz Höllerer, Stefan Weixelbaumer, Marco Vitula and Lukas Zinnagl.
(Disclaimer: Lukas is a semi-regular contributor to TechCrunch Europe).